Can GLP-1s Reduce Alzheimer’s Disease Risk? 🔗 Access full article via Medscape NeurologyCaroline Messer, MD, shares how she prescribed a GLP-1 receptor agonist to a patient as possible low-risk prophylaxis against Alzheimer’s disease. Medscape Diabetes & Endocrinology Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
